Februar 2006 - IOZK

Long-term HIV-specific responses and delayed resumption of antiretroviral therapy after peptide immunization targeting dendritic cells

2006-02-28/in HIV/AIDS, International Publications /von 2006-02-28 / AIDS 2006 Feb;20(4):627-30

Hyperthermia enhances CTL cross-priming

2006-02-15/in Hyperthermia, International Publications /von 2006-02-15 / J. Immunol. 2006 Feb;176(4):2134-41

Specific antihepatocellular carcinoma T cells generated by dendritic cells pulsed with hepatocellular carcinoma cell line HepG2 total RNA

2006-02-10/in Hepatocellular Carcinoma, International Publications /von 2006-02-10 / Cell. Immunol. 2005 Nov;238(1):61-6

Therapeutic cancer vaccines

2006-02-07/in International Publications, Prostate Cancer /von 2006-02-07 / Curr. Opin. Immunol. 2006 Apr;18(2):201-5

Enhancement of anti-tumor immunity specific to murine glioma by vaccination with tumor cell lysate-pulsed dendritic cells engineered to produce interleukin-12

2006-02-04/in Glioblastoma, International Publications /von 2006-02-04 / Cancer Immunol. Immunother. 2006 Nov;55(11):1309-19

Imatinib mesylate minimally affects bcr-abl+ and normal monocyte-derived dendritic cells but strongly inhibits T cell expansion despite reciprocal dendritic cell-T cell activation

2006-02-03/in Chronic Leukemia, International Publications /von 2006-02-03 / J. Leukoc. Biol. 2006 Apr;79(4):747-56

Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost

2006-02-02/in HIV/AIDS, International Publications /von 2006-02-02 / Clin. Immunol. 2006 Apr;119(1):32-7

Preparation of apoptotic tumor cells with replication-incompetent HSV augments the efficacy of dendritic cell vaccines

2006-02-01/in International Publications, Ovarian Cancer /von 2006-02-01 / Cancer Gene Ther. 2006 Feb;13(2):182-93

Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer

2006-02-01/in Dendritic Cells, International Publications, SCLC /von 2006-02-01 / Clin. Cancer Res. 2006 Feb;12(3 Pt 1):878-87

A tumor vaccine containing anti-CD3 and anti-CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes

2006-02-01/in International Publications, Newcastle Disease Virus /von 2006-02-01 / Int. J. Cancer 2006 Feb;118(3):658-67